{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:22:11Z","timestamp":1779916931015,"version":"3.53.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Dermatol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1111\/ced.13283","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T04:46:38Z","timestamp":1511412398000},"page":"149-157","source":"Crossref","is-referenced-by-count":5,"title":["Synergistic inhibition of cell proliferation by combined targeting with kinase inhibitors and dietary xanthone is a promising strategy for melanoma treatment"],"prefix":"10.1093","volume":"43","author":[{"given":"Y.","family":"Xia","sequence":"first","affiliation":[{"name":"Department of Plastic Surgery; Union Hospital; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery; Union Hospital; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,22]]},"reference":[{"key":"10.1111\/ced.13283-BIB0001|ced13283-cit-0001","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1111\/ced.13283-BIB0002|ced13283-cit-0002","first-page":"6483","article-title":"NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression","volume":"9","author":"Omholt","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1111\/ced.13283-BIB0003|ced13283-cit-0003","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/onc.2012.345","article-title":"MAP kinase signaling and inhibition in melanoma","volume":"32","author":"Sullivan","year":"2013","journal-title":"Oncogene"},{"key":"10.1111\/ced.13283-BIB0004|ced13283-cit-0004","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1158\/1078-0432.CCR-11-3227","article-title":"Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner","volume":"18","author":"Khalili","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1111\/ced.13283-BIB0005|ced13283-cit-0005","doi-asserted-by":"crossref","first-page":"11387","DOI":"10.3390\/molecules200611387","article-title":"Xanthones from the leaves of Garcinia cowa induce cell cycle arrest, apoptosis, and autophagy in cancer cells","volume":"20","author":"Xia","year":"2015","journal-title":"Molecules"},{"key":"10.1111\/ced.13283-BIB0006|ced13283-cit-0006","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1101\/gad.17558811","article-title":"The dynamic nature of autophagy in cancer","volume":"25","author":"Kimmelman","year":"2011","journal-title":"Genes Dev"},{"key":"10.1111\/ced.13283-BIB0007|ced13283-cit-0007","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ncb1007-1102","article-title":"Autophagosome formation: core machinery and adaptations","volume":"9","author":"Xie","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1111\/ced.13283-BIB0008|ced13283-cit-0008","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.nutr.27.061406.093749","article-title":"Protein turnover via autophagy: implications for metabolism","volume":"27","author":"Mizushima","year":"2007","journal-title":"Annu Rev Nutr"},{"key":"10.1111\/ced.13283-BIB0009|ced13283-cit-0009","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/carcin\/bgi066","article-title":"Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines","volume":"26","author":"Bloethner","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1111\/ced.13283-BIB0010|ced13283-cit-0010","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/sj.bjc.6604637","article-title":"A novel AKT3 mutation in melanoma tumours and cell lines","volume":"99","author":"Davies","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1111\/ced.13283-BIB0011|ced13283-cit-0011","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1084\/jem.20051848","article-title":"The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells","volume":"203","author":"Sumimoto","year":"2006","journal-title":"J Exp Med"},{"key":"10.1111\/ced.13283-BIB0012|ced13283-cit-0012","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/sj.bjc.6605714","article-title":"Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy","volume":"102","author":"Paraiso","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1111\/ced.13283-BIB0013|ced13283-cit-0013","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1073\/pnas.0811902106","article-title":"Activated Wnt\/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model","volume":"106","author":"Chien","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/ced.13283-BIB0014|ced13283-cit-0014","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1074\/jbc.M705343200","article-title":"GSK-3beta inhibition enhances sorafenib-induced apoptosis in melanoma cell lines","volume":"283","author":"Panka","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1111\/ced.13283-BIB0015|ced13283-cit-0015","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.cellsig.2008.06.001","article-title":"GSK3beta inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes","volume":"20","author":"Bellei","year":"2008","journal-title":"Cell Signal"},{"key":"10.1111\/ced.13283-BIB0016|ced13283-cit-0016","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/0008-5472.CAN-06-1538","article-title":"An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells","volume":"67","author":"Smalley","year":"2007","journal-title":"Cancer Res"},{"key":"10.1111\/ced.13283-BIB0017|ced13283-cit-0017","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/ced.13283-BIB0018|ced13283-cit-0018","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1158\/1078-0432.CCR-09-2074","article-title":"Phase II trial of temozolomide and sorafenib in advanced melanoma patients with or without brain metastases","volume":"15","author":"Amaravadi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1111\/ced.13283-BIB0019|ced13283-cit-0019","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bjc.6603291","article-title":"Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis","volume":"95","author":"Eisen","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1111\/ced.13283-BIB0020|ced13283-cit-0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1200\/JCO.2012.42.1529","article-title":"Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanoma","volume":"31","author":"Flaherty","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1111\/ced.13283-BIB0021|ced13283-cit-0021","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/1440-1681.12436","article-title":"ER stress-induced autophagy in melanoma","volume":"42","author":"Meng","year":"2015","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1111\/ced.13283-BIB0022|ced13283-cit-0022","doi-asserted-by":"crossref","first-page":"ra27","DOI":"10.1126\/scisignal.aaa0899","article-title":"Phosphorylation of eIF2alpha triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma","volume":"8","author":"Wengrod","year":"2015","journal-title":"Sci Signal"},{"key":"10.1111\/ced.13283-BIB0023|ced13283-cit-0023","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1755-148X.2012.00992.x","article-title":"Proteasome inhibition and ROS generation by 4-nerolidylcatechol induces melanoma cell death","volume":"25","author":"Brohem","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1111\/ced.13283-BIB0024|ced13283-cit-0024","first-page":"1913","article-title":"Melanogenesis stimulation in B16-F10 melanoma cells induces cell cycle alterations, increased ROS levels and a differential expression of proteins as revealed by proteomic analysis","volume":"318","author":"Cunha","year":"2012","journal-title":"ExpCell Res"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fced.13283","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ced.13283\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:45:30Z","timestamp":1676385930000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/43\/2\/149\/6597241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,22]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.13283","archive":["Portico"],"relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11,22]]}}}